HLX26
HLX26 is a humanised anti-LAG-3 monoclonal antibody. HLX26 has antitumor activity especially advanced solid tumours. HLX26 can be used for lymphoma research[1].
Product Specifications
UNSPSC
12352203
Target
LAG-3
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]Zhang Y, et al. Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studies. MAbs. 2024 Jan-Dec;16 (1) :2419838.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1085588-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O8 Sulfurtransferase TusA (tusA)
Sign In for Pricing
View Details MBS1085588-02 0.1 mg (E-Coli)
Recombinant Escherichia coli O8 Sulfurtransferase TusA (tusA)
Sign In for Pricing
View Details MBS1085588-03 0.02 mg (Yeast)
Recombinant Escherichia coli O8 Sulfurtransferase TusA (tusA)
Sign In for Pricing
View Details MBS1085588-04 0.1 mg (Yeast)
Recombinant Escherichia coli O8 Sulfurtransferase TusA (tusA)
Sign In for Pricing
View Details MBS1085588-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli O8 Sulfurtransferase TusA (tusA)
Sign In for Pricing
View Details MBS1085588-06 1 mg (E-Coli)
Recombinant Escherichia coli O8 Sulfurtransferase TusA (tusA)
Sign In for Pricing
View Details